NCT04343820

Brief Summary

Breast implants associated with the installation of a complementary matrix (of dermal or synthetic origin), showed satisfactory results in term of post-operative follow-up but also aesthetic outcomes. The objective of the subcutaneous positioning of this implant, is to reduce the muscular pain related to the stretching of the muscular muscle, the deformations related to the muscular contraction with an animation of the prothesis, but also the risk of hull when associated with a matrix. It also pursues the objective, of obtaining a better aesthetic result, by systematically coupling at least one lipo-modelling session. For a long time, patients with a history of mastectomy and radiotherapy benefited from secondary breast flap reconstruction, in order to reduce the risk of complications and achieve a satisfying aesthetic outcome. But the lipo-filling technique allowed to reconsider the management of these patients. The benefits of fat tissue transplants are know to improve tissue trophicity (flexibility, thickness, vascularization). The objective of this study, is to evaluate the feasibility of secondary breast reconstructions by prepectoral positioned implant after lipo-preparation of the wall.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 24, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 13, 2020

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2025

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

5 years

First QC Date

April 10, 2020

Last Update Submit

February 12, 2026

Conditions

Keywords

reconstructionlipo-modellingbreast cancermastectomyprepectoral implant

Outcome Measures

Primary Outcomes (1)

  • Describe the complications that occurs after a prepectoral placed implant with lipo-preparation

    Pre-surgical implant positioning failure at 12 months. A failure will be defined by the occurence of at least one of the following complications : documented infection ; red breast syndrome ; hematoma ; lymphocele ; delayed healing ; prothesis removal ; stage 1 hull (Baker classification) ; prothesis rotation ; waves / folds ; muscle contractions with prothesis animation ; pain (EVA 4 or 5)

    12 months

Secondary Outcomes (2)

  • Evaluate the aesthetic result

    6 months, 12 months and 24 months

  • Evaluate the quality of life

    24 months

Study Arms (1)

Breast reconstruction

Women who have had a mastectomy and want a secondary breast reconstruction by implant.

Procedure: Breast reconstruction

Interventions

Breast reconstruction by prepectoral positioned implant after lipo-preparation of the wall.

Breast reconstruction

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study concerns women who have had a mastectomy and want a secondary breast reconstruction by implant.

You may qualify if:

  • Woman aged over 18
  • Medical history of mastectomy +/- radiotherapy
  • Woman requesting breast reconstruction by implant
  • Patient treated for non-metastatic cancer

You may not qualify if:

  • Locally uncontrolled disease
  • Metastatic disease
  • Patient with major cutaneous atrophy allowing only flap reconstruction
  • Patients under guardianship or trusteeship
  • Patients who objected to the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Cancérologie de l'Ouest René Gauducheau

Saint-Herblain, 44805, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mammaplasty

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Cosmetic TechniquesTherapeuticsPlastic Surgery ProceduresSurgical Procedures, Operative

Study Officials

  • Victoire BRILLAUD-MEFLAH, MD

    Institut de Cancérologie de l'Ouest

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2020

First Posted

April 13, 2020

Study Start

December 24, 2019

Primary Completion

January 7, 2025

Study Completion

January 7, 2025

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations